Neuroleptic malignant syndrome in advanced Parkinson's disease

被引：34

作者：

Gordon, PH ^{[1
]}

Frucht, SJ ^{[1
]}

机构：

[1] Columbia Presbyterian Med Ctr, Dept Neurol, New York, NY 10032 USA

来源：

MOVEMENT DISORDERS | 2001年 / 16卷 / 05期

关键词：

D O I：

10.1002/mds.1166

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Neuroleptic malignant syndrome is a serious complication of levodopa withdrawal in patients with Parkinson's disease. We report a patient with advanced parkinsonism who developed neuroleptic malignant syndrome in the setting of inadequate levodopa intake. His symptoms improved with levodopa replacement. but dramatically worsened when enteral feeding was begun due to interference with intestinal absorption of levodopa. (C) 2001 Movement Disorder Society.

引用

页码：960 / 962

页数：3

共 19 条

[1] Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome [J].

Bertorini, TE .

NEUROLOGIC CLINICS, 1997, 15 (03) :649-+

[2] SEROTONIN SYNDROME [J].

BODNER, RA ;

LYNCH, T ;

LEWIS, L ;

KAHN, D .

NEUROLOGY, 1995, 45 (02) :219-223

[3] The neuroleptic malignant and serotonin syndromes [J].

Carbone, JR .

EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2000, 18 (02) :317-+

[4] Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled is release in parkinsonian patients [J].

Contin, M ;

Riva, R ;

Martinelli, P ;

Albani, F ;

Baruzzi, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) :303-308

[5]

DELAY J, 1965, Bull Mem Soc Med Hop Paris, V116, P487

[6] Neuroleptic malignant syndrome associated with olanzapine [J].

Filice, GA ;

McDougall, BC ;

Ercan-Eang, N ;

Billington, CJ .

ANNALS OF PHARMACOTHERAPY, 1998, 32 (11) :1158-1159

[7] CURRENT CONCEPTS - NEUROLEPTIC MALIGNANT SYNDROME [J].

GUZE, BH ;

BAXTER, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (03) :163-166

[8] FLUOXETINE AND NEUROLEPTIC MALIGNANT SYNDROME [J].

HALMAN, M ;

GOLDBLOOM, DS .

BIOLOGICAL PSYCHIATRY, 1990, 28 (06) :518-521

[9] NEUROLEPTIC MALIGNANT SYNDROME - A PATHOGENETIC ROLE FOR DOPAMINE RECEPTOR BLOCKADE [J].

HENDERSON, VW ;

WOOTEN, GF .

NEUROLOGY, 1981, 31 (02) :132-137

[10] A PROPOSED NEW NOMENCLATURE FOR 5-HT RECEPTORS [J].

HUMPHREY, PPA ;

HARTIG, P ;

HOYER, D .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (06) :233-236

← 1 2 →